Framework Therapeutics L L C - MD Montgomery, Bethesda 20816

Framework Therapeutics L L C entered the industry of Commercial Medical Research in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Gregory K Frykman by calling (301) 965-4325 during business hours. You can also write to the business’ Single Location at 5206 Iroquois Road, Bethesda, Maryland MD 20816. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Framework Therapeutics L L C
Representative: Gregory K Frykman
Place of Business: 5206 Iroquois Road, Bethesda, MD 20816
Contact Number: (301) 965-4325
Type of Service: Commercial Medical Research
SIC Number: 8731
NAICS Number: 541712
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2003
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Framework Therapeutics L L C is a company operating from Montgomery, Maryland providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2003 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.

With a current employee count of 1 to 4, Framework Therapeutics L L C has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Gregory K Frykman at (301) 965-4325 for related queries, or to locate its Single Location using the coordinates 38.960379,-77.125936.

The Single Location can also be found at the street address 5206 Iroquois Road in Bethesda, Maryland 20816 and can be engaged online through the company website at , the company Twitter , and Facebook page .